Catalyst Pharmaceuticals Files 8-K
Ticker: CPRX · Form: 8-K · Filed: Mar 13, 2024 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
Related Tickers: CPRX
TL;DR
Catalyst Pharma filed an 8-K, standard procedure, no major news yet.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on March 13, 2024, to report other events and financial statements. The filing does not contain specific details on new events or financial figures but serves as a notification of these items.
Why It Matters
This filing indicates Catalyst Pharmaceuticals is updating its public disclosures with the SEC, which is a standard procedural requirement for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine procedural update and does not disclose any new material risks or events.
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Registrant
- March 13, 2024 (date) — Date of Report
- 355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134 (location) — Principal executive offices
FAQ
What specific events are being reported under 'Other Events'?
The provided text of the 8-K filing does not specify the details of the 'Other Events' beyond stating that this section is being reported.
What financial statements are being filed with this 8-K?
The filing indicates that 'Financial Statements and Exhibits' are being filed, but the specific content or period covered by these statements is not detailed in the provided text.
What is the Central Index Key (CIK) for Catalyst Pharmaceuticals, Inc.?
The CIK for Catalyst Pharmaceuticals, Inc. is 0001369568.
When was Catalyst Pharmaceuticals, Inc. incorporated and in which state?
Catalyst Pharmaceuticals, Inc. was incorporated in Delaware.
What is the Standard Industrial Classification (SIC) code for Catalyst Pharmaceuticals, Inc.?
The SIC code for Catalyst Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-03-13 17:01:00
Key Financial Figures
- $0.001 — Ticker Symbol Common Stock, par value $0.001 per share NASDAQ Capital Market CPR
Filing Documents
- d798971d8k.htm (8-K) — 25KB
- d798971dex991.htm (EX-99.1) — 18KB
- 0001193125-24-066931.txt ( ) — 169KB
- cprx-20240313.xsd (EX-101.SCH) — 3KB
- cprx-20240313_lab.xml (EX-101.LAB) — 18KB
- cprx-20240313_pre.xml (EX-101.PRE) — 11KB
- d798971d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued by the Company on March 13, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Catalyst Pharmaceuticals, Inc. By: /s/ Michael W. Kalb Michael W. Kalb Executive Vice President and Chief Financial Officer Dated: March 13, 2024 3